PGR and breast carcinoma: In a study conducted by Dehdashti et al., 18F-FFNP PET was shown to be effective in assessing the PR status of individual breast cancer lesions, with the potential to noninvasively and repeatedly evaluate the PR positivity of lesions, aiding in the decision-making for antiestrogen therapy before or after endocrine treatment [88].